113 Foale, R.D., R.A. White, R. Harley, et al. 2003. Left ventricular myxosarcoma in a dog. J Small Anim Pract 44(11):503–507.
114 Forrest, L.J., R. Chun, W.M. Adams, et al. 2000. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 14(6):578–582.
115 Fossum, T.W., C.G. Couto, W.D. DeHoff, et al. 1988. Treatment of hemangiopericytoma in a dog, using surgical excision, radiation, and a thoracic pedicle skin graft. J Am Vet Med Assoc 193(11):1440–1442.
116 Fowler, J.D., D.A. Degner, and R. Walshaw. 1998. Microvascular free tissue transfer: Results in 57 consecutive cases. Vet Surg 27(5):406–412.
117 Fournier, Q., P. Cazzini, S. Bavcar, et al. 2018. Investigation of the utility of lymph node fine‐needle aspiration cytology for the staging of malignant solid tumors in dogs. Vet Clin Pathol 47(3):489–500.
118 Fries, L.F., J. Tartaglia, J. Taylor, et al. 1996. Human safety and immunogenicity of a canarypox‐rabies glycoprotein recombinant vaccine: An alternative poxvirus vector system. Vaccine 14(5): 428–434.
119 Frimberger, A.E., A.S. Moore, S.M. LaRue, et al. 1997. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989–1993). J Am Anim Hosp Assoc 33(4):320–324.
120 Fuerst, J.A., J.K. Reichle, D. Szabo, et al. 2017 Computed tomographic findings in 24 dogs with liposarcoma. Vet Radiol Ultrasound 58(1):23–28.
121 Fukumoto, S., T. Miyasho, K. Hanazono, et al. 2015. Big endothelin‐1 as a tumour marker for canine haemangiosarcoma. Vet J 204(3):269–274.
122 Fulcher, R.P., L.L. Ludwig, P.J. Bergman, et al. 2006. Evaluation of a two‐centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 228(2):210–215.
123 Gagnon, J., M.N. Mayer, T. Belosowsky, et al. 2020. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs. J Am Vet Med Assoc 256:102–110.
124 Gaitero, L., S. Anor, D. Fondevila, et al. 2008. Canine cutaneous spindle cell tumors with features of peripheral nerve sheath tumors: A histopathological and immunohistochemical study. J Comp Pathol 139(1):16–23.
125 Galeotti, F., F. Barzagli, A. Vercelli, et al. 2004. Feline lymphangiosarcoma – definitive identification using a lymphatic vascular marker. Vet Dermatol 15(1):13–18.
126 Ghisleni, G., P. Roccabianca, R. Ceruti, et al. 2006. Correlation between fine‐needle aspiration cytology and histopathology in the evaluation of cutaneous and subcutaneous masses from dogs and cats. Vet Clin Pathol 35(1):24–30.
127 Gieger, T.L., A.P. Theon, J.A. Werner, et al. 2003. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990–2001). J Vet Intern Med 17(5):687–692.
128 Gill, V., N.F. Leibman, S. Monette, et al. 2007. Histologic grade, proliferation indices and clinical outcome in canine subcutaneous mast cell tumors. In Proceedings of the 27th Veterinary Cancer Society Annual conference. Fort Lauderdale, FL, November 1–4, 2007.
129 Gill, V., N. Leibman, S. Monette, et al. 2020. Prognostic indicators and clinical outcome in dogs with subcutaneous mast cell tumors treated with surgery alone: 43 cases. J Am Anim Hosp Assoc 56(4):215–225.
130 Gilson, S.D. and E.A. Stone. 1990. Surgically induced tumor seeding in eight dogs and two cats. J Am Vet Med Assoc 196(11):1811–1815.
131 Gobar, G.M. and P.H. Kass. 2002. World Wide Web‐based survey of vaccination practices, postvaccinal reactions, and vaccine site‐associated sarcomas in cats. J Am Vet Med Assoc 220:1477–1482.
132 Goldschmidt, M.H. and M.J. Hendrick. 2002. Tumors of the skin and soft tissues. In Tumors in Domestic Animals. 4th edition, p. 45. D.J. Meuten, editor. Iowa City: Iowa State Press.
133 Goldschmidt, M.H. and F.S. Shofer. 1992. Skin Tumors of the Dog and Cat, 1st edition. M.H. Goldschmidt and F.S. Shofer, editors. Oxford: Pergamon Press.
134 Goldschmidt, M.H. and F.S. Shofer. 1998. Uncommon skin tumors. In Skin Tumors of the Dog and Cat, pp. 291–295. M.H. Goldschmidt and F.S. Shofer, editors. New York: Butterworth Heinemann.
135 Graf, R., A. Pospischil, F. Guscetti, et al. 2018. Cutaneous tumors in Swiss dogs: Retrospective data from the Swiss Canine Cancer Registry, 2008–2013. Vet Pathol 55(6):809–820.
136 Graves, G.M., D.E. Bjorling, and E. Mahaffey. 1988. Canine hemangiopericytoma: 23 cases (1967–1984). J Am Vet Med Assoc 192(1):99–102.
137 Greene, F.L. 2002. AJCC Cancer Staging Manual. American Joint Committee on Cancer, Report No.: 0387952713. New York: American Cancer Society.
138 Grier, R.L., G. Di Guardo, R. Myers, et al. 1995. Mast cell tumor destruction in dogs by hypotonic solution. J Small Anim Pract 36(9):385–388.
139 Grimes, J.A., S.A. Secrest, N.C. Northrup, et al. 2017. Indirect computed tomography lymphangiography with aqueous contrast for evaluation of sentinel lymph nodes in dogs with tumors of the head. Vet Radiol Ultrasound 58(5):559–564.
140 Grimes, J.A., S.A. Secrest, M.L. Wallace, et al. 2020. Use of indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre‐operative diagnosis of melanoma or mast cell tumour. Vet Comp Oncol 18(4):818–824.
141 Gross, T.L., P.J. Ihrke, E.J. Walder, et al. 2005. Skin Diseases of the Dog and Cat: Clinical Histopathologic Diagnosis, 2nd edition. Oxford: Blackwell Science.
142 Gruntzig, K., R. Graf, M. Hassig, et al. 2015. The Swiss Canine Cancer Registry: A retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol 152(2–3):161–171.
143 Grüntzig, K., R. Graf, G. Boo, et al. 2016. Occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex and neutering status on tumour development. Swiss Canine Cancer Registry 1955–2008. J Comp Pathol 155(2–3):156–170.
144 Haagsman, A.N., A.C. Witkamp, B.E. Sjollema, et al. 2013. The effect of interleukin‐2 on canine peripheral nerve sheath tumors after marginal surgical excision: A double‐blind randomized study. BMC Vet Res 9:155.
145 Hahn, K.A., G.K. King, and J.K. Carreras. 2004. Efficacy of radiation therapy for incompletely resected grade‐III mast cell tumors in dogs: 31 cases (1987–1998). J Am Vet Med Assoc 224(1):79–82.
146 Hahn, K.A., M.M. Endicott, G.K. King, et al. 2007. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989–1999). J Am Vet Med Assoc 231(5):742–745.
147 Hahn, K.A., G. Ogilvie, T. Rusk, et al. 2008. Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med 22(6):1301–1309.
148 Hammer, A.S., C.G. Couto, J. Filppi, et al. 1991. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5(3):160–166.
149 Hanna, S.L. and B.D. Fletcher. 1995. MR imaging of malignant soft tissue tumors. Magn Reson Imaging Clin N Am 3(4):629–650.
150 Hansen, K.S., A.L. Zwingenberger, A.P. Théon, et al. 2016. Treatment of MRI‐diagnosed trigeminal peripheral nerve sheath tumors by stereotactic radiotherapy in dogs. J Vet Intern Med 30(4):1112–1120.
151 Harcourt‐Brown, T.R., N. Granger, P.M. Smith, et al. 2009. Use of a lateral surgical approach to the femoral nerve in the management of two primary femoral nerve sheath tumors. Vet Comp Orthop Traumatol 22(3):229–232.
152 Halsey, C.H., D.R. Worley, K. Curran, et al. 2016. The use of novel lymphatic endothelial cell‐specific immunohistochemical markers to differentiate cutaneous angiosarcomas in dogs. Vet Comp Oncol 14(3):236–244.
153 Hargis, A.M., P.J. Ihrke, W.L. Spangler, et al. 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29(4):316–328.
154 Harris,